| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.064 | 0.2 |